Chinese Yuan: Neutral within defined band against US Dollar – UOB
UOB’s Quek Ser Leang and Lee Sue Ann report a sharp rebound in USD/CNH above 6.78, which invalidated their prior bearish view. They now see the pair as neutral, expecting consolidation between 6.7620 and 6.7980 near term, with 6.7850 and 6.7980 acting as key resistance levels. On a longer horizon, the rebound still has scope to challenge 6.9720.
Dollar-Yuan rebound shifts stance to neutral
"24-HOUR VIEW: Yesterday, we held the view that USD “is likely to edge higher within a range of 6.7610/6.7710.” We did not expect USD to soar to 6.7817. While the sharp rise appears excessive, there is scope for USD to test 6.7850. The next resistance at 6.7980 is unlikely to come under threat. Support is at 6.7700, followed by 6.7660."
"1-3 WEEKS VIEW: We have held a negative USD view since last week. On Tuesday (02 Jun, spot at 6.7640), we indicated the following: “Downward momentum remains mild, but the decline has not stabilised. Overall, only a breach of 6.7800 (‘strong resistance’) would indicate that the decline has stabilised. Until then, USD could continue to edge lower. The next level to watch is 6.7500.” Yesterday, USD staged a strong rebound and broke above 6.7800, printing a high of 6.7817. Downward momentum has faded, and we are neutral on USD now, and expect it to trade between 6.7620 and 6.7980 for the time being."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Strategy (MSTR.US) officially removed from the MSCI index—what does this mean for crypto-related stocks?
Strategy has been officially removed from the MSCI index, with passive funds facing exit pressure. Crypto-related stocks are experiencing "significant" selling pressure.

Biotech Insider Trading in US Stocks Diverges: ImmunityBio (IBRX.US) Cashes Out the Most, Sellas (SLS.US) Director Bought In Before a 5x Surge
Insider trading in US-listed biotech companies shows divergence.
AI investment and consumer spending drive growth! UK Q3 GDP growth rate hits highest in two and a half years
As the widespread adoption of artificial intelligence (AI) continues to drive growth in corporate and consumer spending, and the economy demonstrates resilience in the face of an energy shock caused by the Iran war, the UK economy has achieved its fastest growth rate in two and a half years.

MSCI drops Strategy, Bitcoin eyes $70,000 as ETF outflows hit $300 million

